Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
RN-0191 by Ikaria Bioscience for Hypercholesterolemia: Likelihood of Approval
RN-0191 is under clinical development by Ikaria Bioscience and currently in Phase I for Hypercholesterolemia. According to GlobalData, Phase I...